ArticleJournal for immunotherapy of cancer2026

Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinoma.

Yawei Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.